112 related articles for article (PubMed ID: 31398438)
1. Preparation of H1N1 microneedles by a low-temperature process without a stabilizer.
Jeong HR; Park S; Park JH; Bae JY; Kim GY; Baek SK; Park MS; Park JH
Eur J Pharm Biopharm; 2019 Oct; 143():1-7. PubMed ID: 31398438
[TBL] [Abstract][Full Text] [Related]
2. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
[TBL] [Abstract][Full Text] [Related]
3. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
4. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
5. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
[TBL] [Abstract][Full Text] [Related]
6. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
7. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
[TBL] [Abstract][Full Text] [Related]
8. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
[TBL] [Abstract][Full Text] [Related]
9. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
10. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
11. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
13. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
[TBL] [Abstract][Full Text] [Related]
14. Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.
Vassilieva EV; Wang S; Li S; Prausnitz MR; Compans RW
Sci Rep; 2017 Dec; 7(1):17855. PubMed ID: 29259264
[TBL] [Abstract][Full Text] [Related]
15. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.
Koutsonanos DG; Esser ES; McMaster SR; Kalluri P; Lee JW; Prausnitz MR; Skountzou I; Denning TL; Kohlmeier JE; Compans RW
Vaccine; 2015 Sep; 33(37):4675-82. PubMed ID: 25744228
[TBL] [Abstract][Full Text] [Related]
17. Stability of influenza vaccine coated onto microneedles.
Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
[TBL] [Abstract][Full Text] [Related]
18. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
19. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.
Kim YC; Lee JW; Esser ES; Kalluri H; Joyce JC; Compans RW; Skountzou I; Prausnitz MR
Drug Deliv Transl Res; 2021 Apr; 11(2):692-701. PubMed ID: 33590465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
